Budecort Inhaler


Company name Cipla Ltd.
Generic drug Budesonide
Indications:

Budecort Inhaler is indicated for a wide range of patients with bronchial asthma. These include those whose asthma is poorly controlled by bronchodilators alone; those who are inadequately controlled by sodium cromoglycate in addition to  bronchodilators; those with severe asthma who are dependent on systemic corticosteroids or adrenocorticotrophic hormone (ACTH) or its synthetic equivalent. Budecort Inhalers are particularly important for managing asthma in children because good control can be achieved without retardation of growth.


Presentation  
Formulation type Package type Quantity per pack
---------- 100 mcg Inhaler 200 mdi
---------- 200 mcg Inhaler 200 mdi



Source : Cipla Ltd.
NOTE : The Information presented above is a verbatim rendering of the prescribing information provided by the marketing / manufacturing company which owns the brand.


|Expert's View | Do and Learn | How I Cured | How to Consult a Doctor | Understanding AsthmaDiagnosis | Triggers |
| Therapy | Special Issues Asthma and Allergy | Discussion ForumBooks | Articles | Drugs | Shopping Cart |
 | Medline | Online Consultation | Chat |  
News | Disclaimer | About Us | Advertise |
| FAQ | Contact Us | Feedback | Site Map |Asthma Glossary|

| E-mail webmaster |

© Copyright 2001-2002 Asthmacure.com - All rights reserved
® 
Asthmacure.com
is a registered trademark